E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/29/2014 in the Prospect News PIPE Daily.

Retrophin inks $80 million secured term loan, senior convertibles sale

Offer also includes warrant for 300,000 shares, exercisable at $13.93

By Devika Patel

Knoxville, Tenn., May 29 - Retrophin, Inc. said it arranged a $40 million senior secured term loan facility with Athyrium Capital Management. It also plans a $40 million private placement of senior convertible notes. Barclays and Nomura were the agents for the convertibles. Barclays was the agent for the loan.

The term loan is due in 2018 and accrues interest at Libor plus 100 basis points with a floor of Libor plus 10 basis points.

Athyrium also will receive warrants for 300,000 shares, which are each exercisable at $13.93 for five years. The strike price is identical to the May 28 closing share price.

The 4.5% convertibles are due on May 30, 2019 and are convertible into common stock at an initial conversion rate of 57.43 shares per $1,000 of notes, which is equal to an initial conversion price of about $17.41 per share, a 24.98% premium to the May 28 closing share price.

"We were pleased to obtain non-dilutive financing," founder and chief executive officer Martin Shkreli said in a press release.

"After a thorough process, we chose to partner with Athyrium, not only because they offered the best terms, but because we were most comfortable with their integrity and professionalism. With this financing, we are well-positioned to move forward on several exciting potential acquisitions identified by our business development team."

The biopharmaceutical company is based in New York.

Issuer:Retrophin, Inc.
Issue:Senior secured term loan facility, senior convertible notes
Amount:$80 million
Pricing date:May 29
Stock symbol:Nasdaq: RTRX
Stock price:$13.93 at close May 28
Market capitalization:$314.56 million
Loan
Amount:$40 million
Maturity:2018
Coupon:Libor plus 100 bps
Call:Yes
Warrants:For 300,000 shares
Warrant expiration:Five years
Warrant strike price:$13.93
Agent:Barclays
Investor:Athyrium Capital Management
Convertible note
Amount:$40 million
Maturity:May 30, 2019
Coupon:4.5%
Conversion price:$17.41 (approximate)
Conversion rate:57.43 shares per $1,000 of notes
Conversion premium:24.98%
Warrants:No
Agents:Barclays and Nomura

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.